Rush Ryan Bradford 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-17 5:11 pm Purchase | 2024-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM | Rush Ryan Bradford | 1,050,000 5.100% | 1,050,000 (New Position) | Filing |